BridgeBio Pharma: Late-stage Pipeline Continues to Rapidly Progress With Three Phase 3 Readouts Expected in 2025 >BBIO
BridgeBio Pharma: Late-stage Pipeline Continues to Rapidly Progress With Three Phase 3 Readouts Expected in 2025 >BBIO
bridgebio pharma：晚期研发项目持续快速进展，预计2025年将有三项3期临床试验结果>>bbIO
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间